Helsinn
Helsinn is a subsidiary of global pharmaceutical company Helsinn.
Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals, with the recent additions of medical devices in therapeutic niche areas.
Financial Data
-
31st Dec 16 Source: CRO
- €245.1 million turnover
-
€80.2 million
profit - 177 employees
-
31st Dec 15 Source: CRO
- €197.5 million turnover
-
€63.7 million
profit - 176 employees
- 5 more years available »
Ranking
By Turnover
(€245.1 million)- 262nd in Top Companies
- 36th in Pharma
By Employees
(177)- 595th in Top Companies
- 55th in Pharma
-
- 177
- €245.1 million
Employees
- Padraig Summers CEO/Managing Director
Latest News
- 1:00am Ryanair talks with union due to restart today
- Aug 21 Barclays’ rosiest CRH view sees market value reaching record €38bn
- Aug 21 Feed and water shortages flagged as perilous farm hazards
- Aug 21 S&P 500 reaches record high on Wall Street, European shares nudge up
- Aug 21 Bank of Ireland to sell first set of ‘bail-inable’ senior bonds